1. Report Overview
1.1 Global Infectious Disease Diagnostics Market Overview
1.2 Global Infectious Disease Diagnostics Market Segmentation
1.3 Infectious Disease Diagnostics Report Structure
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. The Global Infectious Disease Diagnostics Market (Disease Type) 2017-2027
2.1 An Introduction to Major Types of Infectious Diseases
2.2 HIV/AIDS
2.2.1 Antibody tests
2.2.2 Combination tests (Antigen/Antibody tests)
2.2.3 Nucleic Acid Tests (NATS)
2.3 Hepatitis
2.3.1 Enzyme test
2.3.2 Viral antibodies
2.4 Tuberculosis
2.5 Malaria
2.6 Chlamydia
3. The Global Infectious Disease Diagnostics Market (Technique) 2017-2027
3.1 An introduction to various types of techniques
3.2 Immunoassay
3.3 Molecular Diagnostics
3.4 Point of care/ rapid diagnosis
3.5 Microbiology
3.5.1 Culture
3.5.2 Microbial identification
3.6 Market Shares by Segment, 2017 and 2027
3.7 World Infectious Disease Diagnostics Market: Forecast by technique 2017-2027
4. The Global Infectious Disease Diagnostics Market (End User) 2017-2027
4.1 An introduction to end users
4.2 Hospitals
4.3 Clinical Laboratories
4.4 Others
4.5 Market Shares by end users, 2017-2027
5. The Global Infectious Disease Diagnostics Market (Geography) 2017-2027
5.1 An Introduction to the Infectious Disease Diagnostics Market by geography
5.2 United States Infectious Disease Diagnostics Market
5.2.1 United States Infectious Disease Diagnostics Market: by disease type
5.2.2 United States Infectious Disease Diagnostics Market: by end user
5.3 EU-5 Infectious Disease Diagnostics Market
5.3.1 EU-5 Infectious Disease Diagnostics Market: by disease type
5.3.2 EU-5 Infectious Disease Diagnostics Market: by End User
5.3.3 EU-5 Infectious Disease Diagnostics Market: by Country
5.3.3.1 Germany
5.3.3.2 France
5.3.3.3 United Kingdom
5.3.3.4 Spain
5.3.3.5 Italy
5.4 Japan Infectious Disease Diagnostics Market
5.4.1 Japan Infectious Disease Diagnostics Market: by disease type
5.4.2 Japan Infectious Disease Diagnostics Market: by End User
5.5 BRIC Infectious Disease Diagnostics Market
5.5.1 BRIC Infectious Disease Diagnostics Market: by disease type
5.5.2 BRIC Infectious Disease Diagnostics Market: by End User
5.5.3 BRIC Infectious Disease Diagnostics Market: by country
5.5.3.1 Brazil
5.5.3.2 India
5.5.3.3 Russia
5.5.3.4 China
6. Leading Companies in Infectious Disease Diagnostics Market
6.1 Introduction
6.2 Abbott Laboratories
6.2.1.1 Business Overview
6.2.1.2 Recent Financials
6.2.1.3 Product Offerings
6.2.1.4 Recent developments
6.3 Becton, Dickinson and Company
6.3.1.1 Business Overview
6.3.1.2 Recent Financials
6.3.1.3 Product Offerings
6.3.1.4 Recent developments
6.4 Biomérieux
6.4.1.1 Business Overview
6.4.1.2 Recent Financials
6.4.1.3 Product Offerings
6.4.1.4 Recent developments
6.5 Bio-Rad Laboratories
6.5.1.1 Business Overview
6.5.1.2 Recent Financials
6.5.1.3 Product Offerings
6.5.1.4 Recent developments
6.6 Alere, Inc
6.6.1.1 Business Overview
6.6.1.2 Recent Financials
6.6.1.3 Product Offerings
6.6.1.4 Recent developments
6.7 Siemens Healthcare
6.7.1.1 Business Overview
6.7.1.2 Recent Financials
6.7.1.3 Product Offerings
6.7.1.4 Recent Developments
6.8 Roche Diagnostics
6.8.1.1 Business Overview
6.8.1.2 Recent Financials
6.8.1.3 Product Offerings
6.8.1.4 Recent Developments
6.9 Danaher Corporation
6.9.1.1 Business Overview
6.9.1.2 Recent Financials:
6.9.1.3 Product and Service Offerings
6.9.1.4 Recent developments
6.10 Thermo-Fisher Scientific, Inc.
6.10.1.1 Recent Financials
6.10.1.2 Product Offerings
6.10.1.3 Recent Developments
6.11 Other Players of Importance within the Global Infectious Disease Diagnostics Industry
7. Qualitative Analysis
7.1 Porter's Five Forces Analysis
7.1.1 Bargaining Power of Buyers
7.1.2 Bargaining Power of Suppliers
7.1.3 Industry Rivalry
7.1.4 Threat of New Entrants
7.1.5 Threat of Substitutes
8. Conclusion and Recommendation
8.1 Key Take-Away
8.2 Conclusion
9. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 2.1 Prevalence of HIV/Aids In Major Countries
Figure 2.2 Incidence Of Hiv Across Various Countries
Figure 2.3 Incidence of Hepatitis Forecast (2017-2027)
Figure 2.4 Forecasted Cases Of Tuberculosis (2017-2027)
Figure 2.5 Forecasted Cases Of Malaria (2017-2027)
Figure 2.6 Forecasted Cases Of Chlamydia (2017-2027)
Figure 3.1 Percentage Contribution Of Individual Segment- 2017
Figure 3.2 Percentage Contribution Of Individual Segment- 2027
Figure 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, 2017-2027
Figure 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.5 Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.1.: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.2: Global Infectious Disease Diagnostics end user: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 4.4: Infectious Disease Diagnostics End-User Market Share (%) 2017
Figure 4.5: Infectious Disease Diagnostics End-User Market Share (%) 2027
Figure 5.1. Infectious Disease Diagnostics Market, Regional Market Share, 2017 (%)
Figure 5.2. Infectious Disease Diagnostics Market, Regional Market Share, 2027 (%)
Figure 5.3: US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR %) 2017-2027
Figure 5.4: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Figure 5.5: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.6: EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR %) 2017-2027
Figure 5.7. Infectious Disease Diagnostics market, Disease cases, 2017-2027, EU-5
Figure 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.9: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.10: Japanese Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.11. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Figure 5.12: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 5.13: BRIC Infectious Disease Diagnostics Market Forecast, By Market (Revenue, $bn, AGR %) 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn) 2017-2027
Figure 7.1 Porter's Five Forces Analysis for the Infectious Disease Diagnostics Market
List of Tables
Table 2.1 Prevalence Forecast of HIV/AIDS in major countries (Mn, 2017-2027)
Table 2.2 Incidence of HIV across various countries (2017-2027)
Table 2.3 Incidence of Hepatitis Forecast (2017-2027)
Table 2.4 Forecasted Incidence Of Tuberculosis (2017-2027)
Table 2.5 Forecasted Incidences of Malaria (2017-2027)
Table 2.6 Incidences of Chlamydia (2017-2027)
Table 3.1 infectious disease diagnoses By Share (%, 2017)
Table 3.2 infectious disease diagnoses By Share (%, 2027)
Table 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, and CAGR %, 2017-2027
Table 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.5: Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.1: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.2: Global Infectious Disease Diagnostics: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.1 : Infectious Disease Diagnostics Market Forecast, (Geographical Distribution, $bn, AGR %) 2017-2027
Table 5.2 : US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.3: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Table 5.4: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.5 : EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.6: EU-5 Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
Table 5.7: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.9. Japanese Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.10. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Table 5.11: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.12: BRIC Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.13 : BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Table 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 6.1 Abbott Laboratories- Key Facts
Table 6.2 Abbott Recent Financials
Table 6.3 Becton, Dickinson and Company- Key Facts
Table 6.4 Becton, Dickinson and Company Recent Financials
Table 6.5 bioMérieux S.A. - Key Facts
Table 6.6 bioMérieux S.A.Recent Financials
Table 6.7 Bio-Rad - Key Facts
Table 6.8 Bio-Rad - Recent Financials
Table 6.9 Alere - Key Facts
Table 6.10 Alere - Recent Financials
Table 6.11 Siemens Healthcare - Key Facts
Table 6.12 Siemens Healthcare - Recent Financials
Table 6.13 Roche Diagnostics - Key Facts
Table 6.14 Danaher Corporation- Key Facts
Table 6.15 Danaher Corporation.- Recent Financials
Table 6.16 Thermo Fisher Scientific Inc.- Key Facts
Table 6.17 Thermo Fisher Scientific Inc.- Recent Financials
Table 6.18: Companies of interest in the Infectious Disease Diagnostics Market
